Factor | N (%) or mean ± SD | Missing (%) | Univariate association with AFIB |
---|---|---|---|
Demographic Factors | Â | Â | Â |
N | 3374 | Â | Â |
Female | 1572 (46.6) | 0 | Â |
African American | 933 (27.7) | 0 | 0.41 (0.24–0.69) |
Mean Age (Years) | 58.9 ± 15.9 | 15 (0.4) |  |
   Quartiles of Age (vs. <48) | 781 |  |  |
   48–60 | 837 |  | 3.54 (1.17–10.76) |
   61–71 | 867 |  | 6.01 (2.06–17.52) |
   >71 | 874 |  | 15.26 (5.46–42.66) |
Cardiovascular Factors | Â | Â | Â |
History of Coronary Heart Disease | 1091 (34.9) | 250 (7.4) | 2.35 (1.60–3.44) |
History of Congestive Heart Failure | 1150 (36.2) | 199 (5.9) | 1.80 (1.24–2.61) |
Chronic Obstructive Lung Disease | 271 (8.6) | 229 (6.8) | 1.93 (1.13–3.40) |
Stroke | 336 (10.5) | 164 (4.9) | 1.69 (1.03–2.81) |
Previous CABG | 325 (9.6) | 118 (3.5) | 1.87 (1.14–3.06) |
Previous PTCA | 174 (5.2) | 203 (6.0) | 2.43 (1.36–4.35) |
Previous coronary angiography | 352 (10.4) | 302 (9.0) | 2.40 (1.51–3.81) |
   2nd quartile of pre-dialysis SBP (130–146 mm Hg) vs. 1st (<130 mm Hg) |  |  | 0.49 (0.25–0.99) |
CKD specific factors | Â | Â | Â |
Ever Transplanted (Yes/No) | 460 (13.6) | NA | 0.15 (0.05–0.48) |
Peritoneal Dialysis | 1662 (49.8) | 37 (1.1) | 0.59 (0.40–0.86) |
Medications | Â | Â | Â |
Aspirin (Yes) | 628 (18.6) | NA | Â |
Coumadin | 198 (5.9) | NA | Â |
Beta-blockers | Â | NA | Â |
   Cardioselective | 486 (14.4) | NA |  |
   Non-cardioselective | 177 (5.2) | NA |  |
Digoxin | 142 (4.2) | NA | 3.72 (2.17–6.38) |
Amiodarone | 19 (0.6) | NA | Â |
Calcium Channel Blockers | Â | NA | Â |
   Non-dihyrdopyridine | 439 (13.0) | NA |  |
   Dihydropyridine | 1371 (40.6) | NA |  |
Statins | 310 (9.2) | NA | Â |
ACE Inhibitors | 772 (22.9) | NA | Â |
Levothyroxine | 330 (9.8) | NA | Â |